Retinal complications of cataract surgery

Comprehensive Ophthalmology Update

Volumn 7, Issue 1, 2006, Pages 1-10

  Ho, Thucanh T ^a,b   Kaiser, Richard ^a,b,c   Benson, William E ^a,b  

^a WILLS EYE HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

Cataract surgery; Cystoid macular edema; Endophthalmitis; Phacoemulsification; Pseudophakic rhegmatogenous retinal detachment

Indexed keywords

ACETAZOLAMIDE; AMIKACIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFUROXIME; CORTICOSTEROID; GATIFLOXACIN; GENTAMICIN; KETOROLAC; MANNITOL; MOXIFLOXACIN; NONSTEROID ANTIINFLAMMATORY AGENT; POVIDONE IODINE; PREDNISOLONE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TRIAMCINOLONE; VANCOMYCIN;

BLEEDING; CATARACT; CATARACT EXTRACTION; CHOROID DETACHMENT; CHOROID HEMORRHAGE; CLINICAL FEATURE; CLINICAL TRIAL; CRYOTHERAPY; DIABETIC RETINOPATHY; DRUG INHIBITION; DRUG MECHANISM; ENDOPHTHALMITIS; HUMAN; HYPOTONY MACULOPATHY; INCIDENCE; INTRAOCULAR PRESSURE ABNORMALITY; LENS IMPLANT; LENS LUXATION; LOW LEVEL LASER THERAPY; META ANALYSIS; NERVE SHEATH; OPTIC NERVE LESION; PERFORATION; PHACOEMULSIFICATION; PHOTOTOXICITY; POSTOPERATIVE COMPLICATION; PSEUDOPHAKIA; RETINA; RETINA BLOOD VESSEL OCCLUSION; RETINA DETACHMENT; RETINA INJURY; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA CYSTOID EDEMA; RETINA MACULA EDEMA; RETINOPEXY; RETROBULBAR HEMORRHAGE; REVIEW; RISK FACTOR; SCLERA BUCKLING PROCEDURE; SCLERECTOMY; SURGICAL DRAINAGE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; UVEITIS; VITRECTOMY; VITREORETINOPATHY; VITREOUS HEMORRHAGE;

CATARACT EXTRACTION; HUMANS; POSTOPERATIVE COMPLICATIONS; RETINAL DISEASES; RISK FACTORS;

EID: 33645744324     PISSN: 15277313     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (106)

1. Hamilton RC: A discourse on the complications of retrobulbar and peribulbar blockade. Can J Ophthalmol 35: 363-72, 2000
2. Ramsay RC, Knobloch WH: Ocular perforation following retrobulbar anesthesia for retinal detachment surgery. Am J Ophthalmol 86: 61-4, 1978
3. Berglin L, Stenkula S, Algvere PV, et al: Ocular perforation during retrobulbar and peribulbar injections. Ophthalmic Surg Lasers 26: 429-34, 1995
4. Grizzard WS, Kirk NM, Pavan PR, et al: Perforating ocular injuries caused by anesthesia personnel. Ophthalmology 98: 1011-6, 1991
5. Ginsburg RN, Duker JS: Globe perforation associated with retrobulbar and peribulbar anesthesia. Semin Ophthalmol 8: 87-95, 1993
6. Duker JS, Belmont JB, Benson WE, et al: Inadvertent globe perforation during retrobulbar and peribulbar anesthesia. Patient characteristics, surgical management, and visual outcome. Ophthalmology 98: 519-26, 1991
7. Leaming DV: Practice styles and preferences of ASCRS members - 1994 survey. J Cataract Refract Surg 21: 378-85, 1995
8. Scott IU, Flynn HW: Retained lens fragments after cataract surgery. Ophthalmol Clin North Am 14: 675-9, 2001
9. Blodi BA, Flynn HW, Blodi CF, et al: Retained nuclei after cataract surgery. Ophthalmology 99: 41-4, 1992
10. Aaberg TM, Rubsamen PE, Flynn HW, et al: Giant retinal tear as a complication of attempted removal of intravitreal lens fragments during cataract surgery. Am J Ophthalmol 124: 222-6, 1997
11. Yang CS, Lee FL, Hsu WM, et al: Management of retained intravitreal lens fragments after phacoemulsification surgery. Ophthalmologica 216: 192-7, 2002
12. Hansson LJ, Larsson J: Vitrectomy for retained lens fragments in the vitreous after phacoemulsification. J Cataract Refract Surg 28: 1007-11, 2002
13. Scott IU, Flynn HW, Smiddy WE, et al: Clinical features and outcomes of pars plana vitrectomy in patients with retained lens fragments. Ophthalmology 110: 1567-72, 2003
14. Ling R, Cole M, James C, et al: Suprachoroidal haemorrhage complicating cataract surgery in the UK: epidemiology, clinical features, management, and outcomes. Br J Ophthalmol 88: 478-80, 2004
15. Eriksson A, Koranyi G, Seregard S, et al: Risk of acute suprachoroidal hemorrhage with phacoemulsification. J Cataract Refract Surg 24: 793-800, 1998
16. Davison JA: Acute intraoperative suprachoroidal hemorrhage in capsular bag phacoemulsification. J Cataract Refract Surg 19: 534-7, 1993
17. Welch JC, Spaeth GL, Benson WE: Massive suprachoroidal hemorrhage. Follow-up and outcome of 30 cases. Ophthalmology 95: 1202-6, 1988
18. Wirostko WJ, Han DP, Mieler WF, et al: Suprachoroidal hemorrhage: outcome of surgical management according to hemorrhage severity. Ophthalmology 105: 2271-5, 1998
19. Powe NR, Schein OD, Gieser SC, et al: Synthesis of the literature on visual acuity and complications following cataract extraction with intraocular lens implantation. Cataract Patient Outcome Research Team. Arch Ophthalmol 112: 239-52, 1994
20. Eifrig CW, Flynn HW, Scott IU, et al: Acute-onset postoperative endophthalmitis: review of incidence and visual outcomes (1995-2001). Ophthalmic Surg Lasers 33: 373-8, 2002
21. Fisch A, Salvanet A, Prazuck T, et al: Epidemiology of infective endophthalmitis in France. The French Collaborative Study Group on Endophthalmitis. Lancet 338: 1373-6, 1991
22. Han DP, Wisniewski SR, Wilson LA, et al: Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. Am J Ophthalmol 122: 1-17, 1996
23. Johnson MW, Doft BH, Kelsey SF, et al: The Endophthalmitis Vitrectomy Study. Relationship between clinical presentation and microbiologic spectrum. Ophthalmology 104: 261-72, 1997
24. Egger SF, Huber-Spitzy V, Skorpik C, et al: Different techniques of extracapsular cataract extraction: bacterial contamination during surgery. Prospective study on 230 consecutive patients. Graefes Arch Clin Exp Ophthalmol 232: 308-11, 1994
25. ?5. Nagaki Y, Hayasaka S, Kadoi C, et al: Bacterial endophthalmitis after small-incision cataract surgery, effect of incision placement and intraocular lens type. J Cataract Refract Surg 29: 20-6, 2003
26. Schmitz S, Dick HB, Krummenauer F, et al: Endophthalmitis in cataract surgery: results of a German survey. Ophthalmology 106: 1869-77, 1999
27. Cooper BA, Holekamp NM, Bohigian G, et al: Case-control study of endophthalmitis after cataract surgery comparing scleral tunnel and clear corneal wounds. Am J Ophthalmol 136: 300-5, 2003
28. Speaker MG, Milch FA, Shah MK, et al: Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology 98: 639-49; discussion 650, 1991
29. Bannerman TL, Rhoden DL, McAllister SK, et al: The source of coagulase-negative staphylococci in the Endophthalmitis Vitrectomy Study. A comparison of eyelid and intraocular isolates using pulsed-field gel electrophoresis. Arch Ophthalmol 115: 357-61, 1997
30. Ciulla TA, Starr MB, Masket S: Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology 109: 13-24, 2002
31. Montan PG, Koranyi G, Setterquist HE, et al: Endophthalmitis after cataract surgery: risk factors relating to technique and events of the operation and patient history: a retrospective case-control study. Ophthalmology 105: 2171-7, 1998
32. Montan PG, Wejde G, Setterquist H, et al: Prophylactic intracameral cefuroxime. Evaluation of safety and kinetics in cataract surgery. J Cataract Refract Surg 28: 982-7, 2002
33. Wilson FM: Causes and prevention of endophthalmitis. Int Ophthalmol Clin 27: 67-73, 1987
34. Mather R, Karenchak LM, Romanowski EG, et al: Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 133: 463-6, 2002
35. Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Endophthalmitis Vitrectomy Study Group. Arch Ophthalmol 113: 1479-96, 1995
36. Rowe JA, Erie JC, Baratz KH, et al: Retinal detachment in Olmsted County, Minnesota, 1976 through 1995. Ophthalmology 106: 154-9, 1999
37. Tielsch JM, Legro NIW, Cassard SD, et al: Risk factors for retinal detachment after cataract surgery. A population-based case-control study Ophthalmology 103: 1537-45, 1996
38. Javitt JC, Vitale S, Canner JK, et al: National outcomes of cataract extraction. I. Retinal detachment after inpatient surgery. Ophthalmology 98: 895-902, 1991
39. Davison JA: Retinal tears and detachments after extracapsular cataract surgery. J Cataract Refract Surg 14: 624-32, 1998
40. Tornambe PE, Hilton GF, Brinton DA, et al: Pneumatic retinopexy. A two-year follow-up study of the multicenter clinical trial comparing pneumatic retinopexy with scleral buckling. Ophthalmology 98: 1115-23, 1991
41. Grizzard WS, Hilton GF, Hammer ME, et al: Pneumatic retinopexy failures. Cause, prevention, timing, and management. Ophthalmology 102: 929-36, 1995
42. Campo RV, Sipperley JO, Sneed SR, et al: Pars plana vitrectomy without scleral buckle for pseudophakic retinal detachments. Ophthalmology 106: 1811-5; discussion 1816, 1999
43. Speicher MA, Fu AD, Martin JP, et al: Primary vitrectomy alone for repair of retinal detachments following cataract surgery. Retina 20: 459-64, 2000
44. Newman DK, Burton RL: Primary vitrectomy for pseudophakic and aphakic retinal detachments. Eye 13 (Pt 5): 635-9, 1999
45. Devenyi RG, de Carvalho Nakamura H: Combined scleral buckle and pars plana vitrectomy as a primary procedure for pseudophakic retinal detachments. Ophthalmic Surg Lasers 30: 615-8, 1999
46. Irvine SR: A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol 36: 499-619, 1953
47. Gass JD, Norton EW: Fluorescein studies of patients with macular edema and papilledema following cataract extraction. Trans Am Ophthalmol Soc 64: 232-49, 1966
48. Flach AJ: The incidence, pathogenesis and treatment of cystoid macular edema following cataract surgery. Trans Am Ophthalmol Soc 96: 557-634, 1998
49. Nelson ML, Martidis A: Managing cystoid macular edema after cataract surgery. Curr Opin Ophthalmol 14: 39-43, 2003
50. Rossetti L, Autelitano A: Cystoid macular edema following cataract surgery. Curr Opin Ophthalmol 11: 65-72, 2000
51. Flach AJ, Stegman RC, Graham J, Kruger LP: Prophylaxis of aphakic cystoid macular edema without corticosteroids. A paired-comparison, placebo-controlled double-masked study. Ophthalmology 97: 1253-8, 1990
52. Flach AJ, Stegman RC, Graham J, et al: Prophylaxis of aphakic cystoid macular edema without corticosteroids. A paired-comparison, placebo-controlled double-masked study. Ophthalmology 97: 1253-8, 1990
53. Rossetti L, Chaudhuri J, Dickersin K: Medical prophylaxis and treatment of cystoid macular edema after cataract surgery. The results of a meta-analysis. Ophthalmology 105: 397-405, 1998
54. Heier JS, Topping TM, Baumann W, et al: Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmology 107: 2034-8; discussion 2039, 2000
55. Martidis A, Duker JS, Greenberg PB, et al: Intravitreal triamcinolone for refractory diabetic macular edema. Ophthalmology 109: 920-7, 2002
56. Danis RP, Ciulla TA, Pratt LM, et al: Intravitreal triamcinolone acetonide in exudative age-related macular degeneration. Retina 20: 244-50, 2000
57. Park CH, Jaffe GJ, Fekrat S: Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion. Am J Ophthalmol 136: 419-25, 2003
58. Benhamou N, Massin P, Haouchine B, et al: Intravitreal triamcinolone for refractory pseudophakic macular edema. Am J Ophthalmol 135: 246-9, 2003
59. Karacorlu M, Ozdemir H, Karacorlu S: Intravitreal triamcinolone acetonide for the treatment of chronic pseudophakic cystoid macular oedema. Acta Ophthalmol Scand 81: 648-52, 2003
60. Beer PM, Bakri SJ, Singh RJ, et al: Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection. Ophthalmology 110: 681-6, 2003
61. Jonas JB, Degenring RF, Kamppeter BA, et al: Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema. Am J Ophthalmol 138: 158-60, 2004
62. Singh IP, Ahmad SI, Yeh D, et al: Early rapid rise in intraocular pressure after intravitreal triamcinolone acetonide injection. Am J Ophthalmol 138: 286-7, 2004
63. Jager RD, Aiello LP, Patel SC, et al: Risks of intravitreous injection: a comprehensive review. Retina 24: 676-98, 2004
64. Nelson ML, Tennant MT, Sivalingam A, et al: Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection. Retina 23: 686-91, 2003
65. Gillies MC, Simpson JM, Billson FA, et al: Safety of an intravitreal injection of triamcinolone: results from a randomized clinical trial. Arch Ophthalmol 122: 336-40, 2004
66. Klein BE, Klein R, Moss SE: Incidence of cataract surgery in the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Am J Ophthalmol 119: 295-300, 1995
67. Cheng H, Franklin SL: Treatment of cataract in diabetics with and without retinopathy. Eye 2 (Pt 6): 607-14, 1988
68. Cunliffe IA, Flanagan DW, George ND, et al: Extracapsular cataract surgery with lens implantation in diabetics with and without proliferative retinopathy. Br J Ophthalmol 75: 9-12, 1991
69. Benson WE, Brown GC, Tasman W, et al: Extracapsular cataract extraction with placement of a posterior chamber lens in patients with diabetic retinopathy. Ophthalmology 100: 730-8, 1993
70. Jaffe GJ, Burton TC, Kuhn E, et al: Progression of nonproliferative diabetic retinopathy and visual outcome after extracapsular cataract extraction and intraocular lens implantation. Am J Ophthalmol 114: 448-56, 1992
71. Schatz H, Atienza D, McDonald HR, et al: Severe diabetic retinopathy after cataract surgery. Am J Ophthalmol 117: 314-21, 1994
72. Pollack A, Dotan S, Oliver M: Progression of diabetic retinopathy after cataract extraction. Br J Ophthalmol 75: 547-51, 1991
73. Chew EY, Benson WE, Remaley NA, et al: Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25. Arch Ophthalmol 117: 1600-6, 1999
74. Henricsson M, Heijl A, Janzon L: Diabetic retinopathy before and after cataract surgery. Br J Ophthalmol 80: 789-93, 1996
75. Dowler JG, Sehmi KS, Hykin PG, et al: The natural history of macular edema after cataract surgery in diabetes. Ophthalmology 106: 663-8, 1999
76. Squirrell D, Bhola R, Bush J, et al: A prospective, case controlled study of the natural history of diabetic retinopathy and maculopathy after uncomplicated phacoemulsification cataract surgery in patients with type 2 diabetes. Br J Ophthalmol 86: 565-71, 2002
77. Krepier K, Biowski R, Schrey S, et al: Cataract surgery in patients with diabetic retinopathy: visual outcome, progression of diabetic retinopathy, and incidence of diabetic macular oedema. Graefes Arch Clin Exp Ophthalmol 240: 735-8, 2002
78. Wagner T, Knaflic D, Rauber M, et al: Influence of cataract surgery on the diabetic eye: a prospective study. Ger J Ophthalmol 5: 79-83, 1996
79. Boot JP, van Gerven JM, van Best JA, et al: Blood retinal and blood aqueous barriers in diabetics by fluorophotometry. Doc Ophthalmol 71: 19-27, 1989
80. Ferguson VM, Spalton DJ: Continued breakdown of the blood aqueous barrier following cataract surgery. Br J Ophthalmol 76: 453-6, 1992
81. Laurell CG, Zetterström C, Lundgren B, et al: Inflammatory response in the rabbit after phacoemulsification and intraocular lens implantation using a 5.2 or 11.0 mm incision. J Cataract Refract Surg 23: 126-31, 1997
82. Brown RM, Roberts CW: Preoperative and postoperative use of nonsteroidal antiinflammatory drugs in cataract surgery. Insight 21: 13-6, 1996
83. Dowler JG, Hykin PG, Hamilton AM: Phacoemulsification versus extracapsular cataract extraction in patients with diabetes. Ophthalmology 107: 457-62, 2000
84. Mittra RA, Borrillo JL, Dev S, et al: Retinopathy progression and visual outcomes after phacoemulsification in patients with diabetes mellitus. Arch Ophthalmol 118: 912-7, 2000
85. Ciardella AP, Klancnik J, Schiff W, et al: Intravitreal triamcinolone for the treatment of refractory diabetic macular oedema with hard exudates: an optical coherence tomography study. Br J Ophthalmol 88: 1131-6, 2004
86. Jonas JB, Degenring RF, Kamppeter BA, et al: Duration of the effect of intravitreal triamcinolone acetonide as treatment for diffuse diabetic macular edema. Am J Ophthalmol 138: 158-60, 2004
87. Massin P, Audren F, Haouchine B, et al: Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 111: 218-24; discussion 224-5, 2004
88. Lam DS, Chan CK, Mohamed S, et al: Phacoemulsification with intravitreal triamcinolone in patients with cataract and coexisting diabetic macular oedema: a 6-month prospective pilot study. Eye 19: 885-90, 2005
89. Klein R, Klein BE, Wong TY, et al: The association of cataract and cataract surgery with the long-term incidence of age-related maculopathy: the Beaver Dam eye study. Arch Ophthalmol 120: 1551-8, 2002
90. Wang JJ, Klein R, Smith W, et al: Cataract surgery and the 5-year incidence of late-stage age-related maculopathy: pooled findings from the Beaver Dam and Blue Mountains eye studies. Ophthalmology 110: 1960-7, 2003
91. Freeman EE, Munoz B, West SK, et al: Is there an association between cataract surgery and age-related macular degeneration? Data from three population-based studies. Am J Ophthalmol 135: 849-56, 2003
92. Kleinmann G, Hoffman P, Schechtman E, et al: Microscope-induced retinal phototoxicity in cataract surgery of short duration. Ophthalmology 109: 334-8, 2002
93. Penfold PL, Provis JM, Billson FA: Age-related macular degeneration: ultrastructural studies of the relationship of leucocytes to angiogenesis. Graefes Arch Clin Exp Ophthalmol 225: 70-6, 1987
94. Sparrow JR, Nakanishi K, Parish CA: The lipofuscin fluorophore A2E mediates blue light-induced damage to retinal pigmented epithelial cells. Invest Ophthalmol Vis Sci 41: 1981-9, 2000
95. Boulton M, Rózanowska M, Rózanowski B: Retinal photodamage. J Photochem Photobiol B 64: 144-61, 2001
96. Rozanowska M, Jarvis-Evans J, Korytowski W, et al: Blue light-induced reactivity of retinal age pigment. In vitro generation of oxygen-reactive species. J Biol Chem 270: 18825-30, 1995
97. Schmidt SY, Peisch RD: Melanin concentration in normal human retinal pigment epithelium. Regional variation and age-related reduction. Invest Ophthalmol Vis Sci 27: 1063-7, 1986
98. Klein R, Klein BE, Cruickshanks KJ: The prevalence of age-related maculopathy by geographic region and ethnicity. Prog Retin Eye Res 18: 371-89, 1999
99. Liang FQ, Godley BF: Oxidative stress-induced mitochondrial DNA damage in human retinal pigment epithelial cells: a possible mechanism for RPE aging and age-related macular degeneration. Exp Eye Res 76: 397-403, 2003
100. Tomany SC, Cruickshanks KJ, Klein R, et al: Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Arch Ophthalmol 122: 750-7, 2004
101. Taylor HR, West S, Munoz B, et al: The long-term effects Divisible light on the eye. Arch Ophthalmol 110: 99-104, 1992
102. Sparrow JR, Miller AS, Zhou J: Blue light-absorbing intraocular lens and retinal pigment epithelium protection in vitro. J Cataract Refract Surg 30: 873-8, 2004
103. Mainster MA, Sparrow JR: How much blue light should an IOL transmit?. Br J Ophthalmol 87: 1523-9, 2003
104. Armbrecht AM, Findlay C, Aspinall PA, et al: Cataract surgery in patients with age-related macular degeneration: one-year outcomes. J Cataract Refract Surg 29: 686-93, 2003
105. Lundström M, Brege KG, Florén I, et al: Cataract surgery and quality of life in patients with age related macular degeneration. Br J Ophthalmol 86: 1330-5, 2002
106. Shuttleworth GN, Luhishi EA, Harrad RA: Do patients with age related maculopathy and cataract benefit from cataract surgery?. Br J Ophthalmol 82: 611-6, 1998